Myostatin represses physiological hypertrophy of the heart and excitation-contraction coupling

Journal of Physiology

Volumn 587, Issue 20, 2009, Pages 4873-4886

  Rodgers, Buel D ^a,b   Interlichia, Jillian P ^a   Garikipati, Dilip K ^b   Mamidi, Ranganath ^c   Chandra, Murali ^c   Nelson, O Lynne ^d   Murry, Charles E ^e   Santana, Luis F ^f  

^a Department of Animal Sciences ^*  (United States)

^b Center for Reproductive Biology   (United States)

^c Pharmacology and Physiology   (United States)

^d WASHINGTON STATE UNIVERSITY   (United States)

^e Department of Pathology   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; BINDING PROTEIN; CALCIUM ION; MYOSTATIN; SOMATOMEDIN; ACTIVIN LIKE KINASE 4; ACTIVIN LIKE KINASE 5; BETA ACTIN; CALCIUM CHANNEL L TYPE; FOLLISTATIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CALCIUM TRANSPORT; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; EXCITATION CONTRACTION COUPLING; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART VENTRICLE; IN VIVO STUDY; MOUSE; MUSCLE FUNCTION; MUSCLE GROWTH; MYOFILAMENT; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOPLASMIC RETICULUM; WILD TYPE; BINDING AFFINITY; FEMALE; FUNCTIONAL ASSESSMENT; HEART EJECTION FRACTION; MALE; MUSCLE CELL; PHYSIOLOGICAL PROCESS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN MODIFICATION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; THORACOTOMY;

ADRENERGIC BETA-AGONISTS; ANIMALS; CALCIUM; CARDIOMEGALY; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; HEART; HEART DISEASES; HUMANS; ISOPROTERENOL; MICE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; MYOSTATIN; RATS; REGENERATION;

EID: 70350658270     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2009.172544     Document Type: Article

References (50)

1. Abergel E, Chatellier G, Hagege AA, Oblak A, Linhart A, Ducardonnet A, Menard J. Serial left ventricular adaptations in world-class professional cyclists: implications for disease screening and follow-up. J Am Coll Cardiol 2004, 44:144-149.
2. Adams GR. Invited Review: Autocrine/paracrine IGF-I and skeletal muscle adaptation. J Appl Physiol 2002, 93:1159-1167.
3. Artaza JN, Reisz-Porszasz S, Dow JS, Kloner RA, Tsao J, Bhasin S, Gonzalez-Cadavid NF. Alterations in myostatin expression are associated with changes in cardiac left ventricular mass but not ejection fraction in the mouse. J Endocrinol 2007, 194:63-76.
4. Catalucci D, Latronico MV, Ellingsen O, Condorelli G. Physiological myocardial hypertrophy: how and why?. Front Biosci 2008, 13:312-324.
5. Chandra M, Rundell VL, Tardiff JC, Leinwand LA, De Tombe PP, Solaro RJ. Ca2+ activation of myofilaments from transgenic mouse hearts expressing R92Q mutant cardiac troponin T. Am J Physiol Heart Circ Physiol 2001, 280:H705-713.
6. Chandra M, Tschirgi ML, Rajapakse I, Campbell KB. Troponin T modulates sarcomere length-dependent recruitment of cross-bridges in cardiac muscle. Biophys J 2006, 90:2867-2876.
7. Claessens C, Claessens P, Claessens M, Claessens J. Echocardiographic and physiological performance characteristics of triathletes. Can J Cardiol 2000, 16:993-1002.
8. Cohn RD, Liang HY, Shetty R, Abraham T, Wagner KR. Myostatin does not regulate cardiac hypertrophy or fibrosis. Neuromuscul Disord 2007, 17:290-296.
9. Colan SD. Mechanics of left ventricular systolic and diastolic function in physiologic hypertrophy of the athlete heart. Cardiol Clin 1992, 10:227-240.
10. Cook SA, Matsui T, Li L, Rosenzweig A. Transcriptional effects of chronic Akt activation in the heart. J Biol Chem 2002, 277:22528-22533.
11. de Tombe PP, Stienen GJ. Protein kinase A does not alter economy of force maintenance in skinned rat cardiac trabeculae. Circ Res 1995, 76:734-741.
12. Drummond AE, Le MT, Ethier JF, Dyson M, Findlay JK. Expression and localization of activin receptors, Smads, and βglycan to the postnatal rat ovary. Endocrinology 2002, 143:1423-1433.
13. Esposito G, Santana LF, Dilly K, Cruz JD, Mao L, Lederer WJ, Rockman HA. Cellular and functional defects in a mouse model of heart failure. Am J Physiol Heart Circ Physiol 2000, 279:H3101-3112.
14. Farnworth PG, Wang Y, Leembruggen P, Ooi GT, Harrison C, Robertson DM, Findlay JK. Rodent adrenocortical cells display high affinity binding sites and proteins for inhibin A, and express components required for autocrine signalling by activins and bone morphogenetic proteins. J Endocrinol 2006, 188:451-465.
15. Garikipati DK, Gahr SA, Roalson EH, Rodgers BD. Characterization of rainbow trout myostatin-2 genes (rtMSTN-2a and -2b): Genomic organization, differential expression, and pseudogenization. Endocrinology 2007, 148:2106-2115.
16. Garikipati DK, Gahr SA, Rodgers BD. Identification, characterization, and quantitative expression analysis of rainbow trout myostatin-1a and myostatin-1b genes. J Endocrinol 2006, 190:879-888.
17. Gaussin V, Depre C. Myostatin, the cardiac chalone of insulin-like growth factor-1. Cardiovasc Res 2005, 68:347-349.
18. Gordon AM, Homsher E, Regnier M. Regulation of contraction in striated muscle. Physiol Rev 2000, 80:853-924.
19. Helterline DL, Garikipati D, Stenkamp DL, Rodgers BD. Embryonic and tissue-specific regulation of myostatin-1 and -2 gene expression in zebrafish. Gen Comp Endocrinol 2007, 151:90-97.
20. Kamanga-Sollo E, Pampusch MS, White ME, Dayton WR. Role of insulin-like growth factor binding protein (IGFBP)-3 in TGF-β- and GDF-8 (myostatin)-induced suppression of proliferation in porcine embryonic myogenic cell cultures. J Cell Physiol 2003, 197:225-231.
21. Kamanga-Sollo E, Pampusch MS, White ME, Hathaway MR, Dayton WR. Insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-5 mediate TGF-β- and myostatin-induced suppression of proliferation in porcine embryonic myogenic cell cultures. Exp Cell Res 2005, 311:167-176.
22. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, Reinecke H, Xu C, Hassanipour M, Police S, O'Sullivan C, Collins L, Chen Y, Minami E, Gill EA, Ueno S, Yuan C, Gold J, Murry CE. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007, 25:1015-1024.
23. Langley B, Thomas M, Bishop A, Sharma M, Gilmour S, Kambadur R. Myostatin inhibits myoblast differentiation by down regulating MyoD expression. J Biol Chem 2002, 277:49831-49840.
24. Lee SJ, Reed LA, Davies MV, Girgenrath S, Goad ME, Tomkinson KN, Wright JF, Barker C, Ehrmantraut G, Holmstrom J, Trowell B, Gertz B, Jiang MS, Sebald SM, Matzuk M, Li E, Liang LF, Quattlebaum E, Stotish RL, Wolfman NM. Regulation of muscle growth by multiple ligands signalling through activin type II receptors. Proc Natl Acad Sci U S A 2005, 102:18117-18122.
25. Leung GP, Tse CM, Man RY. Characterization of adenosine transport in H9c2 cardiomyoblasts. Int J Cardiol 2007, 116:186-193.
26. Li ZB, Kollias HD, Wagner KR. Myostatin directly regulates skeletal muscle fibrosis. J Biol Chem 2008, 283:19371-19378.
27. McKoy G, Bicknell KA, Patel K, Brooks G. Developmental expression of myostatin in cardiomyocytes and its effect on foetal and neonatal rat cardiomyocyte proliferation. Cardiovasc Res 2007, 74:304-312.
28. McMullen JR, Jennings GL. Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure. Clin Exp Pharmacol Physiol 2007, 34:255-262.
29. Menard C, Pupier S, Mornet D, Kitzmann M, Nargeot J, Lory P. Modulation of L-type calcium channel expression during retinoic acid-induced differentiation of H9C2 cardiac cells. J Biol Chem 1999, 274:29063-29070.
30. Morissette MR, Cook SA, Foo S, McKoy G, Ashida N, Novikov M, Scherrer-Crosbie M, Li L, Matsui T, Brooks G, Rosenzweig A. Myostatin regulates cardiomyocyte growth through modulation of Akt signalling. Circ Res 2006, 99:15-24.
31. Muller PY, Janovjak H, Miserez AR, Dobbie Z. Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 2002, 32:1378-1379.
32. Nomura T, Ashihara E, Tateishi K, Ueyama T, Takahas-Hi T, Yamagishi M, Kubo T, Yaku H, Matsubara H, Oh H. Therapeutic potential of stem/progenitor cells in human skeletal muscle for cardiovascular regeneration. Curr Stem Cell Res Ther 2007, 2:293-300.
33. Oufattole M, Lin SW, Liu B, Mascarenhas D, Cohen P, Rodgers BD. Ribonucleic acid polymerase II binding subunit 3 (Rpb3), a potential nuclear target of insulin-like growth factor binding protein-3. Endocrinology 2006, 147:2138-2146.
34. Pampusch MS, Xi G, Kamanga-Sollo E, Loseth KJ, Hathaway MR, Dayton WR, White ME. Production of recombinant porcine IGF-binding protein-5 and its effect on proliferation of porcine embryonic myoblast cultures in the presence and absence of IGF-I and Long-R3-IGF-I. J Endocrinol 2005, 185:197-206.
35. Pavlik G, Bachl N, Wollein W, Langfy G, Prokop L. Resting echocardiographic parameters after cessation of regular endurance training. Int J Sports Med 1986, 7:226-231.
36. Pluim BM, Zwinderman AH, Van Der Laarse A, Van Der Wall EE. The athlete's heart. A meta-analysis of cardiac structure and function. Circulation 2000, 101:336-344.
37. Poolman RA, Brooks G. Expressions and activities of cell cycle regulatory molecules during the transition from myocyte hyperplasia to hypertrophy. J Mol Cell Cardiol 1998, 30:2121-2135.
38. Reisz-Porszasz S, Bhasin S, Artaza JN, Shen R, Sinha-Hikim I, Hogue A, Fielder TJ, Gonzalez-Cadavid NF. Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin. Am J Physiol Endocrinol Metab 2003, 285:E876-888.
39. Robey TE, Murry CE. Absence of regeneration in the MRL/MpJ mouse heart following infarction or cryoinjury. Cardiovasc Pathol 2008, 17:6-13.
40. Rodgers BD, Garikipati DK. Clinical, agricultural, and evolutionary biology of myostatin: a comparative review. Endocr Rev 2008, 29:513-534.
41. Santana LF, Chase EG, Votaw VS, Nelson MT, Greven R. Functional coupling of calcineurin and protein kinase A in mouse ventricular myocytes. J Physiol 2002, 544:57-69.
42. Shao C, Liu M, Wu X, Ding F. Time-dependent expression of myostatin RNA transcript and protein in gastrocnemius muscle of mice after sciatic nerve resection. Microsurgery 2007, 27:487-493.
43. Sharma M, Kambadur R, Matthews KG, Somers WG, Devlin GP, Conaglen JV, Fowke PJ, Bass JJ. Myostatin, a transforming growth factor-β superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct. J Cell Physiol 1999, 180:1-9.
44. Shyu KG, Ko WH, Yang WS, Wang BW, Kuan P. Insulin-like growth factor-1 mediates stretch-induced upregulation of myostatin expression in neonatal rat cardiomyocytes. Cardiovasc Res 2005, 68:405-414.
45. Stout M. Athletes' heart and echocardiography: athletes' heart. Echocardiography 2008, 25:749-754.
46. Takehara-Kasamatsu Y, Tsuchida K, Nakatani M, Murakami T, Kurisaki A, Hashimoto O, Ohuchi H, Kurose H, Mori K, Kagami S, Noji S, Sugino H. Characterization of follistatin-related gene as a negative regulatory factor for activin family members during mouse heart development. J Med Invest 2007, 54:276-288.
47. Van Den Berg G, Somi S, Buffing AA, Moorman AF, Van Den Hoff MJ. Patterns of expression of the Follistatin and Follistatin-like1 genes during chicken heart development: a potential role in valvulogenesis and late heart muscle cell formation. Anat Rec (Hoboken) 2007, 290:783-787.
48. Whyte G, Lumley S, George K, Gates P, Sharma S, Prasad K, McKenna WJ. Physiological profile and predictors of cycling performance in ultra-endurance triathletes. J Sports Med Phys Fitness 2000, 40:103-109.
49. Xi G, Hathaway MR, White ME, Dayton WR. Localization of insulin-like growth factor (IGFBP)-3 in cultured porcine embryonic myogenic cells before and after TGF-β1 treatment. Domest Anim Endocrinol 2007, 33:422-429.
50. Xi G, Kamanga-Sollo E, Hathaway MR, Dayton WR, White ME. Effect of constitutive expression of porcine IGFBP-3 on proliferation and differentiation of L6 myogenic cells. Domest Anim Endocrinol 2005, 31:35-51.